期刊
CHEMOSPHERE
卷 278, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.chemosphere.2021.130376
关键词
Photocatalytic degradation; Ibuprofen; BiOBr; Doping; Oxygen vacancies
资金
- Research Council of the Hong Kong Special Administrative Region, China [14304019]
- National Natural Science Foundation of China [51902357]
- Natural Science Foundation of Guangdong Province, China [2019A1515012143]
Doping S into the lattice of BiOBr to synthesize S-BiOBr significantly enhances the degradation efficiency and kinetic constant for the visible-light-driven degradation of ibuprofen. This is attributed to the band structure tuning by S-doping, leading to higher visible light utilization efficiency. OH radicals play a synergistic role with holes in the degradation process on S-BiOBr, which is more efficient than the reported single hole- or superoxide-dominant reactions.
Doping heterogeneous atoms into BiOX is recognized as an effective method to improve its photo-catalytic activity. Here, S-doped BiOBr (S-BiOBr) was synthesized via a solvothermal method in the absence of water, which is supposed to substitute O as S2- in the lattice. This material is firstly used for the visible-light-driven degradation of ibuprofen, a model anti-inflammatory drug. The degradation efficiency of S-BiOBr is much higher than that of pure BiOBr. The degradation kinetic constant for S-BiOBr (2.48 x 10(-2) min(-1)) is about 3 times as high as that of pure BiOBr (0.83 x 10(-2) min(-1)). It is found that S-doping tunes the band structure of BiOBr, leading to a narrower band gap and thus higher utilization efficiency of visible light. The degradation of ibuprofen on S-BiOBr can be attributed to the generation of H2O2 and OH radicals. OH radical plays a synergistic role along with holes in the photo-catalytic degradation process, which is supposed to be better than the reported single hole- or superoxide-dominant reaction. This work reveals a previously unrecognized and more efficient method for the degradation of organic contaminants on BiOBr. (C) 2021 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据